GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Guangdong Bawei Biotechnology Corp (BJSE:837023) » Definitions » Asset Impairment Charge

Guangdong Bawei Biotechnology (BJSE:837023) Asset Impairment Charge : ¥0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Guangdong Bawei Biotechnology Asset Impairment Charge?

Guangdong Bawei Biotechnology's Asset Impairment Charge for the three months ended in Sep. 2024 was ¥0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.0 Mil.

Guangdong Bawei Biotechnology Asset Impairment Charge Historical Data

The historical data trend for Guangdong Bawei Biotechnology's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Bawei Biotechnology Asset Impairment Charge Chart

Guangdong Bawei Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Guangdong Bawei Biotechnology Quarterly Data
Mar18 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Guangdong Bawei Biotechnology Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Guangdong Bawei Biotechnology Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Guangdong Bawei Biotechnology's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Bawei Biotechnology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Guangdong Bawei Biotechnology Corp (BJSE:837023) » Definitions » Asset Impairment Charge
Comparable Companies
Traded in Other Exchanges
N/A
Address
Xinbei Road, No. 5, Baiyun District, Guangdong Province, Guangzhou, CHN, 510450
Website
http://www.gzbawei.com
Guangdong Bawei Biotechnology Corp is engaged in product planning, formula research and development, manufacturing, and efficacy testing of cosmetics.

Guangdong Bawei Biotechnology Headlines

No Headlines